Univo Pharmaceuticals (XTAE:UNVO-M) ROCE % : -136.01% (As of Jun. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Univo Pharmaceuticals's annualized ROCE % for the quarter that ended in Jun. 2022 was -136.01%.

Univo Pharmaceuticals ROCE % Historical Data

The historical data trend for Univo Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals ROCE % Chart

Univo Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

-2,801.04

-54.95

0.01

-0.95

Univo Pharmaceuticals Quarterly Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
ROCE %	Get a 7-Day Free Trial													56.03	-8.07	-21.83	-12.76	-136.01

Univo Pharmaceuticals ROCE % Calculation

Univo Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-0.667	/	( ( (73.996 - 9.629)	+	(101.128 - 25.313) )	/ 2 )
	=	-0.667	/	( (64.367	+	75.815)	/ 2 )
	=	-0.667	/	70.091
	=	-0.95 %

Univo Pharmaceuticals's ROCE % of for the quarter that ended in Jun. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2022 )		(Q: Mar. 2022 )		(Q: Jun. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2022 )		(Q: Mar. 2022 )		(Q: Jun. 2022 )
	=	-83.604	/	( ( (95.498 - 22.73)	+	(75.939 - 25.772) )	/ 2 )
	=	-83.604	/	( ( 72.768	+	50.167 )	/ 2 )
	=	-83.604	/	61.4675
	=	-136.01 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2022) EBIT data.

Univo Pharmaceuticals (XTAE:UNVO-M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Univo Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Univo Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harshar 20, Ashkelon, ISR, 7878329

Website

https://www.univopharma.com

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines